MiNK Therapeutics, Inc. (INKT) plans to release its financial results for the first quarter of 2026
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
At the same time, the company will also highlight the R&D progress made by its proprietary platform in several iNKT cell therapy projects. This information release aims to provide investors with a comprehensive understanding of the company's financial condition and the advancement of its core therapeutic technology pipeline.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Piper Sandler lowers Home Depot target price to $378
格隆汇•2026/05/21 09:46
Applied Digital(APLD.US) surged over 12% in pre-market trading
格隆汇•2026/05/21 09:44
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$77,675.79
+0.29%
Ethereum
ETH
$2,127.21
-0.05%
Tether USDt
USDT
$0.9990
+0.00%
BNB
BNB
$652.82
+1.41%
XRP
XRP
$1.37
+0.27%
USDC
USDC
$0.9997
-0.01%
Solana
SOL
$86.44
+1.82%
TRON
TRX
$0.3611
+1.21%
Dogecoin
DOGE
$0.1053
+1.45%
Hyperliquid
HYPE
$58.4
+19.50%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now